Growth Metrics

Merck (MRK) Assets Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.21%
Dec 31, 2025 8.37%
Sep 30, 2025 7.60%
Jun 30, 2025 5.34%
Mar 31, 2025 6.28%
Dec 31, 2024 6.77%
Sep 30, 2024 7.12%
Jun 30, 2024 6.05%
Mar 31, 2024 5.15%
Dec 31, 2023 5.24%
Sep 30, 2023 4.63%
Jun 30, 2023 4.20%
Mar 31, 2023 4.61%
Dec 31, 2022 4.43%
Sep 30, 2022 3.16%
Jun 30, 2022 2.91%
Mar 31, 2022 2.01%
Dec 31, 2021 2.08%
Sep 30, 2021 -1.00%
Jun 30, 2021 -1.23%
Mar 31, 2021 -1.66%
Dec 31, 2020 -2.07%
Sep 30, 2020 -2.37%
Jun 30, 2020 -2.45%
Mar 31, 2020 -4.76%
Dec 31, 2019 -2.98%
Sep 30, 2019 -3.93%
Jun 30, 2019 -3.02%
Mar 31, 2019 -5.36%
Dec 31, 2018 -4.79%
Sep 30, 2018 -4.37%
Jun 30, 2018 -4.47%
Dec 31, 2017 -3.71%
Jun 30, 2017 -2.54%
Mar 31, 2017 -1.76%
Dec 31, 2016 -1.93%
Sep 30, 2016 -1.59%
Jun 30, 2016 -1.90%
Mar 31, 2016 -1.38%
Dec 31, 2015 -0.79%
Sep 30, 2015 -1.26%
Jun 30, 2015 -0.69%
Mar 31, 2015 -0.59%
Dec 31, 2014 -2.66%
Sep 30, 2014 27.22%
Jun 30, 2014 27.06%